Whitney Ijem

Stock Analyst at Canaccord Genuity

(3.27)
# 955
Out of 4,896 analysts
101
Total ratings
47.67%
Success rate
2.64%
Average return

Stocks Rated by Whitney Ijem

Verve Therapeutics
Jun 17, 2025
Downgrades: Hold
Price Target: $39$13
Current: $11.03
Upside: +17.86%
Taysha Gene Therapies
Jun 3, 2025
Maintains: Buy
Price Target: $9$11
Current: $2.64
Upside: +316.67%
Rocket Pharmaceuticals
Jun 3, 2025
Maintains: Buy
Price Target: $34$11
Current: $2.96
Upside: +271.62%
Intellia Therapeutics
Jun 3, 2025
Maintains: Buy
Price Target: $74$54
Current: $11.54
Upside: +368.14%
Palvella Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $53$52
Current: $26.50
Upside: +96.23%
Arcturus Therapeutics Holdings
May 13, 2025
Maintains: Buy
Price Target: $68$66
Current: $13.78
Upside: +378.96%
Rhythm Pharmaceuticals
Apr 8, 2025
Maintains: Buy
Price Target: $81$92
Current: $86.70
Upside: +6.11%
Alnylam Pharmaceuticals
Mar 21, 2025
Maintains: Buy
Price Target: $385$390
Current: $314.94
Upside: +23.83%
Generation Bio Co.
Mar 17, 2025
Maintains: Buy
Price Target: $9
Current: $0.39
Upside: +2,229.19%
Tenaya Therapeutics
Mar 13, 2025
Maintains: Buy
Price Target: $18$6
Current: $0.68
Upside: +778.22%
Maintains: Buy
Price Target: $121$136
Current: $29.51
Upside: +360.86%
Upgrades: Hold
Price Target: $408$424
Current: $468.85
Upside: -9.57%
Maintains: Buy
Price Target: $13
Current: $0.40
Upside: +3,142.70%
Maintains: Buy
Price Target: $148$150
Current: $18.17
Upside: +725.54%
Maintains: Hold
Price Target: $93$84
Current: $58.10
Upside: +44.58%
Downgrades: Neutral
Price Target: n/a
Current: $109.64
Upside: -
Upgrades: Overweight
Price Target: $120$240
Current: $4.55
Upside: +5,174.73%